SC 13D Filing

Company

GALECTIN THERAPEUTICS INC

Filed

March 18, 2009

Accession Number

0001456614-09-000002

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →